rs34236495

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_000092.5(COL4A4):​c.2008G>A​(p.Val670Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0029 in 1,612,738 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 67 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 47 hom. )

Consequence

COL4A4
NM_000092.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0440
Variant links:
Genes affected
COL4A4 (HGNC:2206): (collagen type IV alpha 4 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. This particular collagen IV subunit, however, is only found in a subset of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Mutations in this gene are associated with type II autosomal recessive Alport syndrome (hereditary glomerulonephropathy) and with familial benign hematuria (thin basement membrane disease). Two transcripts, differing only in their transcription start sites, have been identified for this gene and, as is common for collagen genes, multiple polyadenylation sites are found in the 3' UTR. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 5 uncertain in NM_000092.5
BP4
Computational evidence support a benign effect (MetaRNN=0.0026720762).
BP6
Variant 2-227062578-C-T is Benign according to our data. Variant chr2-227062578-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 255018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-227062578-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0504 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
COL4A4NM_000092.5 linkuse as main transcriptc.2008G>A p.Val670Ile missense_variant 26/48 ENST00000396625.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
COL4A4ENST00000396625.5 linkuse as main transcriptc.2008G>A p.Val670Ile missense_variant 26/485 NM_000092.5 P1

Frequencies

GnomAD3 genomes
AF:
0.0151
AC:
2287
AN:
151836
Hom.:
67
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0524
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00466
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000280
Gnomad OTH
AF:
0.0154
GnomAD3 exomes
AF:
0.00390
AC:
972
AN:
249510
Hom.:
22
AF XY:
0.00297
AC XY:
402
AN XY:
135378
show subpopulations
Gnomad AFR exome
AF:
0.0553
Gnomad AMR exome
AF:
0.00226
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.00164
AC:
2396
AN:
1460784
Hom.:
47
Cov.:
30
AF XY:
0.00143
AC XY:
1038
AN XY:
726780
show subpopulations
Gnomad4 AFR exome
AF:
0.0547
Gnomad4 AMR exome
AF:
0.00253
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000580
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000221
Gnomad4 OTH exome
AF:
0.00315
GnomAD4 genome
AF:
0.0151
AC:
2288
AN:
151954
Hom.:
67
Cov.:
32
AF XY:
0.0142
AC XY:
1054
AN XY:
74274
show subpopulations
Gnomad4 AFR
AF:
0.0523
Gnomad4 AMR
AF:
0.00465
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000280
Gnomad4 OTH
AF:
0.0152
Alfa
AF:
0.00328
Hom.:
21
Bravo
AF:
0.0174
ESP6500AA
AF:
0.0492
AC:
185
ESP6500EA
AF:
0.000488
AC:
4
ExAC
AF:
0.00468
AC:
565
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 09, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 21, 2016p.Val670Ile in exon 26 of COL4A4: This variant is not expected to have clinical significance because it has been identified in 5.39% (526/9750) of African chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs34236495). -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsFeb 28, 2018- -
Alport syndrome Benign:2
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Benign familial hematuria;C4746745:Autosomal recessive Alport syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 15, 2021- -
Focal segmental glomerulosclerosis Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenJun 04, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
5.7
DANN
Benign
0.94
DEOGEN2
Benign
0.066
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.60
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
0.17
N
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.010
N
REVEL
Benign
0.075
Sift
Benign
1.0
T
Sift4G
Benign
0.70
T
Polyphen
0.017
B
Vest4
0.15
MVP
0.56
MPC
0.27
ClinPred
0.0024
T
GERP RS
0.61
Varity_R
0.032
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34236495; hg19: chr2-227927294; COSMIC: COSV61631610; API